DPP4 and type 2 diabetes mellitus: A recent study showed that in patients with GD and type 2 diabetes, DPP4 inhibitors administration was significantly associated with GD exacerbation, which suggested that DPP4 might play a critical role in the pathogenesis of GD [12].